<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Vulvar pain of unknown cause (vulvodynia): Clinical manifestations and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Vulvar pain of unknown cause (vulvodynia): Clinical manifestations and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Vulvar pain of unknown cause (vulvodynia): Clinical manifestations and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Cheryl Iglesia, MD, FACOG</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert L Barbieri, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Apr 13, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1040399308"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Localized vulvar pain syndrome is a persistent vulvar pain that can be consistently and precisely localized to the vulvar vestibule during physical examination, has no identifiable cause, and has been present for at least three months. This syndrome has previously been referred to as vulvodynia, vestibulodynia, vulvar vestibulitis, and focal vulvitis.</p><p>This topic will review the clinical manifestations and diagnosis of localized vulvar pain syndrome. Information on treatment of vulvar pain, generalized vulvar pain syndromes, and sexual pain in women is presented separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5432.html" rel="external">"Female sexual pain: Evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5409.html" rel="external">"Female sexual pain: Differential diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H2124190159"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>In 2015, representatives from the International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women's Sexual Health, and the International Pelvic Pain Society developed consensus terminology and classified persistent vulvar pain into two categories [<a href="#rid1">1</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vulvar pain</strong> <strong>caused by a specific disorder</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vulvodynia</strong> (ie, persistent vulvar pain without an identifiable etiology) </p><p></p><p>Examples of vulvar pain caused by a specific disorder include infectious, inflammatory, neoplastic, and neurologic processes  (<a class="graphic graphic_table graphicRef105906" href="/z/d/graphic/105906.html" rel="external">table 1</a>). By contrast, vulvodynia is defined as vulvar pain of at least three months duration that has no identifiable cause.</p><p>Vulvodynia can be further subdivided by [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Location – The symptoms can be localized (eg, vestibulodynia, clitorodynia), generalized, or mixed (localized and generalized)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Provocation – Provoked (eg, insertional, contact), spontaneous, or mixed (provoked and spontaneous)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Onset – Primary or secondary (primary symptoms have always been present, such as with tampon insertion or sexual intercourse; secondary symptoms develop after a period of normal function)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Temporal pattern – Intermittent, persistent, constant, immediate (ie, symptomatic immediately after physical contact), or delayed (symptoms delayed after contact)</p><p></p><p>Localized vulvar pain syndrome is the most common vulvodynia and may include the clitoris (clitorodynia) as well as the vulvar vestibule (vestibulodynia) (see <a class="local">'Diagnostic criteria'</a> below). Localized vulvar pain syndrome is typically provoked or worsened with direct touch, but may occur spontaneously.</p><p class="headingAnchor" id="H3379950284"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Although localized vulvar pain syndrome appears to be the most common subtype of chronic vulvar pain of unknown etiology [<a href="#rid3">3</a>], the incidence and prevalence are not known because of the factors below and because the diagnostic criteria have changed (erythema is no longer included in the diagnosis [<a href="#rid4">4,5</a>]). The prevalence of chronic vulvar pain (all types) ranges from 3 to 15 percent in self-report studies [<a href="#rid6">6-9</a>]. Assessing prevalence is challenging because many women with vulvar pain do not present for evaluation and the condition is frequently misdiagnosed when they are seen [<a href="#rid10">10</a>]. Additionally, patients presenting with vestibular pain may have heterogenous presentations with other chronic overlapping pain conditions, leading to generalized pain at other sites within the pelvis and exacerbated by contributing factors such as vulvovaginal infections, hypoestrogenic states, and disorders related to anxiety, depression, catastrophizing, and other psychosocial factors [<a href="#rid11">11,12</a>]. </p><p>Vulvodynia is considered the most frequent cause of dyspareunia among premenopausal women, with an estimated prevalence of 12 percent among community-dwelling women [<a href="#rid13">13</a>]. In a study of over 2250 women who completed a self-administered validated questionnaire, just under one-half of the women meeting criteria for vulvodynia sought treatment, and only 1.4 percent of the women evaluated were actually diagnosed with vulvodynia [<a href="#rid14">14</a>]. A different population-based study of 441 women who screened positive for vulvodynia reported that 51 percent experienced remission over 6 to 30 months (with no relapse) while 10 percent had persistent symptoms [<a href="#rid15">15</a>]. The need for careful inclusion criteria when studying vulvodynia is highlighted by a retrospective case review of 525 women with isolated vulvar pain in which over 60 percent were diagnosed with a dermatologic condition that responded to appropriate treatment; these patients do not meet the criteria for vulvar pain of unknown cause [<a href="#rid16">16</a>]. (See <a class="local">'Terminology'</a> above.)</p><p class="headingAnchor" id="H2248446881"><span class="h1">PATHOGENESIS AND LIKELY CONTRIBUTORS</span><span class="headingEndMark"> — </span>The etiology of localized vulvar pain syndrome is not fully known and is likely multifactorial [<a href="#rid10">10,17</a>]. The leading hypothesis is that an inciting event, such as infection or trauma, initiates a local inflammatory response [<a href="#rid3">3</a>]. In susceptible women, the inflammatory response causes the proliferation of nerve fibers in the vestibular tissue and lowered pain thresholds, which can then lead to central sensitization of pain [<a href="#rid18">18-21</a>]. (See  <a class="medical medical_review" href="/z/d/html/116196.html" rel="external">"Evaluation of chronic non-cancer pain in adults"</a>.)</p><p class="headingAnchor" id="H144180981"><span class="h2">Inflammation</span><span class="headingEndMark"> — </span>An excessive or abnormal immune response has been postulated as a cause of vulvodynia, although the data are mixed. A systematic review of 18 studies, including 400 women, found limited and contradictory evidence for an association of local and systemic inflammation on localized vulvodynia [<a href="#rid22">22</a>]. Increased production of pro-inflammatory chemicals and/or limited ability of tissues to clear the inflammatory response could sensitize neurons in the vulvar vestibule and cause up-regulation of neurons in the central nervous system [<a href="#rid10">10</a>]. Studies have reported an increase in the inflammatory markers interleukin-6, interleukin-1, and tumor necrosis factor-alpha and a decrease in the macrophage inhibitory protein 1-beta [<a href="#rid23">23-25</a>]. The surface receptor Dectin-1, which binds <em>Candida albicans</em>, is also increased in women with vestibular pain compared with control women [<a href="#rid26">26</a>]. Therefore, women with vestibular pain syndromes may have an increased propensity to bind <em>C. albicans</em> and release an inflammatory chemical response compared with asymptomatic women.</p><p>While the above studies support the role of an abnormal immune response in women with localized vulvar pain syndrome, older studies have not noted differences among affected and asymptomatic women. Analyses of tissue biopsies reported similar nonspecific inflammatory cellular infiltrates, immunohistochemical results, and inflammatory mediators among women with localized vulvar pain syndrome and asymptomatic women [<a href="#rid27">27-29</a>]. However, these studies were limited by use of cellular and histochemical techniques, which are less sensitive than the molecular and genomic analyses performed in later studies. (See  <a class="medical medical_review" href="/z/d/html/2893.html" rel="external">"Tools for genetics and genomics: Cytogenetics and molecular genetics"</a>.)</p><p class="headingAnchor" id="H181249093"><span class="h2">Neurologic proliferation and sensitization</span><span class="headingEndMark"> — </span>In women with localized vulvar pain syndrome, studies have reported increased density of intra-epithelial nerve fibers [<a href="#rid30">30,31</a>], increased vanilloid receptor VR1 (which is triggered by the inflammatory response) [<a href="#rid32">32</a>], and hyperesthesia, which results from sensitization of the peripheral and central nervous systems [<a href="#rid33">33,34</a>]. Additionally, reduced sensory and pressure-pain thresholds have been reported in patients with localized vulvar pain syndrome [<a href="#rid35">35-38</a>]. Chronic inflammation of the vulvar vestibule may lead to hyperinnervation and sensitization such that even light touch to the vulva is transformed into a significantly painful response (allodynia)  (<a class="graphic graphic_figure graphicRef55588" href="/z/d/graphic/55588.html" rel="external">figure 1</a>). A retrospective study of 39 patients with refractory chronic pelvic pain reported approximately two-thirds of patients demonstrated small fiber polyneuropathy, as identified by lower extremity punch biopsy [<a href="#rid39">39</a>]. Additionally, pain can persist after the original infection or insult has cleared. </p><p class="headingAnchor" id="H3248829041"><span class="h2">Infection</span><span class="headingEndMark"> — </span>Studies have reported an association between genital infection, particularly with <em>C. albicans</em> and bacterial vaginosis, and localized vulvar pain syndrome [<a href="#rid40">40,41</a>]. Approximately 70 percent of women with vulvodynia report a history of frequent or severe yeast infections [<a href="#rid4">4,42-44</a>]. Additionally, increasing number of pelvic infections appears to increase the risk of having localized vulvar pain syndrome [<a href="#rid40">40</a>]. While these data are limited by small sample sizes and use of self-report as evidence of prior infection [<a href="#rid40">40,41</a>], an abnormal immune response to genital infection has been demonstrated in women with vulvodynia [<a href="#rid23">23-25</a>]. Other nonimmune contributors to postinfection pain syndromes likely include agent-specific characteristics, host susceptibility, altered vaginal microbiota, altered chemical metabolites produced by the disturbed flora (vaginal metabolome), development of abnormal pelvic floor muscle response during or after infection, and early central sensitization of pain [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H3490730659"><span class="h2">Genetic factors</span><span class="headingEndMark"> — </span>Genetic polymorphisms may impair the immune system response to trauma or infection, decrease the ability to terminate the inflammatory response, or increase the susceptibility to pain after exposure to infectious agents [<a href="#rid10">10,45</a>]. Genetic polymorphisms for interleukin-1 beta, tumor necrosis factor-alpha, interleukin-1 receptor antagonist, mannose-binding lectin, and melanocortin-1 receptor have been associated with vulvar pain [<a href="#rid45">45-49</a>]. Women with localized vulvar pain syndrome appear to produce a more severe inflammatory reaction (eg, increased interleukin-1 beta) and have alterations in their ability to resolve inflammatory reactions (eg, impaired interleukin-1 receptor antagonist) [<a href="#rid50">50,51</a>]. Increased cytosine-adenine-guanine (CAG) repeats in genes coding for androgen receptors have been noted in adolescents with vulvar pain that develops in response to combined hormonal contraceptives compared with control patients; these are postulated to be due to decreased free <a class="drug drug_general" data-topicid="9981" href="/z/d/drug information/9981.html" rel="external">testosterone</a> [<a href="#rid52">52,53</a>].</p><p class="headingAnchor" id="H2866242"><span class="h2">Allergy</span><span class="headingEndMark"> — </span>Allergic reaction has been associated with local vulvar pain syndrome. In one study of 220 women with localized vulvar pain syndrome, 20 percent had a vaginal allergy (defined as elevated immunoglobulin E levels) and nearly half were successfully treated with antihistamine medications [<a href="#rid54">54</a>]. In a histopathologic study of 12 women with localized vulvar pain syndrome and 12 asymptomatic women, 75 percent of women with localized vulvar pain syndrome had immunoglobin G positive plasma cells compared with none in control women [<a href="#rid55">55</a>]. Lastly, in a study that performed skin patch testing with candida, women with vulvodynia needed lower concentrations of <em>C. albicans</em> to elicit a response and affected women produced a greater response compared with control women [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H1344048950"><span class="h2">Hormonal</span><span class="headingEndMark"> — </span>The impact of reproductive hormones on development of vulvodynia is not clear. Studies have reported both decreased [<a href="#rid57">57</a>] and increased [<a href="#rid58">58</a>] levels of estrogen receptor alpha in women with localized vulvar pain syndrome compared with control women. Similarly, data on the impact of contraceptive hormone pills on vestibular pain are conflicting. In two population-based studies, no significant association was found between past or current oral contraceptive use and adult-onset vulvodynia [<a href="#rid59">59,60</a>]. However, other studies reported lower mechanical pain thresholds and increased risk of developing vulvar vestibular pain with oral contraceptive use [<a href="#rid61">61-64</a>]. Women with weaker androgen receptors may be more susceptible to vulvodynia during hormonal contraceptive use [<a href="#rid52">52</a>]. Hormonal alterations may explain why obese women (body mass index [BMI] ≥30 kg/m<sup>2</sup>) are less likely to have resolution of localized vulvar pain syndrome than normal-weight women (BMI 18.5 to 24.9 kg/m<sup>2</sup>) [<a href="#rid65">65</a>].</p><p class="headingAnchor" id="H3143597769"><span class="h2">Myofascial</span><span class="headingEndMark"> — </span>Pelvic floor muscle dysfunction can exacerbate localized vulvar pain symptoms [<a href="#rid66">66</a>]. Additionally, pelvic myofascial disorders or pelvic floor hypertonus can develop in patients with vulvodynia because contact with the vulvar vestibule causes pain, which triggers a reflex contraction and resultant increased tension in the levator ani and other pelvic floor muscles [<a href="#rid67">67,68</a>]. (See  <a class="medical medical_review" href="/z/d/html/5480.html" rel="external">"Myofascial pelvic pain syndrome in females: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H1482350147"><span class="h2">Psychological dysfunction</span><span class="headingEndMark"> — </span>The relationship between psychological dysfunction and localized vulvar pain syndrome is debated. Women with localized vulvar pain syndrome exhibit lower pain thresholds, increased systemic pain perception, anxiety, depression, hypervigilance, and somatization compared with women without vulvodynia [<a href="#rid57">57,61,69,70</a>]. However, overall, there is no evidence for a primary psychological cause for localized vulvar pain syndrome. Consequences of the mental health stigma associated with vulvar pain can include dismissive experiences within the health care system, feelings of shame and guilt, low self-esteem, social isolation, and negative social narratives surrounding sexuality and femininity [<a href="#rid71">71</a>]. The chronic pain associated with this condition can lead to secondary psychological and mental health disorders, and patients with psychiatric disorders or a history of sexual assault [<a href="#rid72">72</a>] may be more susceptible to chronic pain. (See  <a class="medical medical_review" href="/z/d/html/116196.html" rel="external">"Evaluation of chronic non-cancer pain in adults", section on 'Psychiatric comorbidity'</a>.) </p><p>Examples of the conflicting nature of the data include:</p><p class="bulletIndent1"><span class="glyph">●</span>In one large United-Kingdom-based retrospective cohort study of 22,604 adult women exposed to domestic abuse, compared with 44,671 matched controls (unexposed women), history of abuse was associated with the development of chronic lower back pain, chronic headaches, and irritable bowel syndrome but not with the development of vulvodynia [<a href="#rid73">73</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a Swedish population registry of over one million women aged 15 to 43, early adverse events at birth such as preterm birth, low birth weight, and low Apgar scores were associated with the development of provoked vestibulodynia later in life [<a href="#rid74">74</a>]. </p><p></p><p class="headingAnchor" id="H967937143"><span class="h1">DIAGNOSTIC CRITERIA</span><span class="headingEndMark"> — </span>The criteria for localized vulvar pain syndrome include [<a href="#rid10">10</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Pain localized to the vulvar vestibule, with or without the clitoris</p><p class="bulletIndent1"><span class="glyph">●</span>Absence of identifiable cause</p><p class="bulletIndent1"><span class="glyph">●</span>Duration of at least three months</p><p class="bulletIndent1"><span class="glyph">●</span>Pain elicited with pressure-point testing</p><p></p><p>Additionally, the timing of symptom onset can be primary (from initial vestibular contact) or secondary (develop after a period of normal function). Symptoms can have multiple temporal patterns (ie, intermittent, persistent [nonrelapsing], or constant [continuous]) and variable timing after vestibular contact (ie, immediate or delayed). The most common form of the disorder is provoked by genital contact in an otherwise asymptomatic woman. Other variants include women with spontaneous pain or both provoked and spontaneous symptoms.</p><p>Vulvar pain of known etiology and localized vulvar pain syndrome can coexist; women can have a specific vulvar disorder such as lichen sclerosus, herpes, or candida and have concomitant vulvodynia. These women are typically identified when their vulvodynia symptoms persist after treatment of all identified causes of vulvar pain.</p><p class="headingAnchor" id="H659269905"><span class="h1">CLINICAL PRESENTATION</span><span class="headingEndMark"> — </span>The hallmark symptom in women with localized vulvar pain syndrome is significant pain upon contact with the vulvar vestibule  (<a class="graphic graphic_picture graphicRef105677" href="/z/d/graphic/105677.html" rel="external">picture 1</a>). Common clinical complaints include pain with vaginal intercourse, tampon insertion, tight clothing, prolonged sitting, biking, or other sports. Pain onset can be immediate or delayed and discomfort can persist or resolve on its own. Most affected women are between 20 and 60 years of age [<a href="#rid10">10</a>], but symptoms can begin in childhood or adolescence [<a href="#rid18">18,75</a>]. Additionally, the pain is sufficiently severe to limit sexual function, cause psychological distress, impair relationships, and/or adversely affect routine activities [<a href="#rid10">10,17,76</a>]. (See <a class="local">'Diagnostic criteria'</a> above.)</p><p class="headingAnchor" id="H2514017211"><span class="h1">DIAGNOSTIC EVALUATION</span><span class="headingEndMark"> — </span>The diagnostic evaluation consists of a detailed history and physical examination that includes focal pressure-point testing of the vulvar vestibule. One purpose of the evaluation is to identify potential specific causes of the woman's pain, such as infection or genitourinary syndrome of menopause. Localized vulvar pain syndrome is a diagnosis of exclusion; women with an identifiable cause of symptoms have specified vulvar pain and do not meet the defining criteria for localized vulvar pain syndrome. However, the diagnostic process can be confusing as vulvar pain from a specific cause can coexist with localized vulvar pain syndrome [<a href="#rid1">1</a>]. (See <a class="local">'Diagnostic criteria'</a> above.)</p><p class="headingAnchor" id="H4001063322"><span class="h2">History</span><span class="headingEndMark"> — </span>The history includes a comprehensive review of systems, detailed gynecologic history, and vulvar pain history to characterize the patient's pain and identifies potential specific causes of vulvar pain  (<a class="graphic graphic_table graphicRef105906" href="/z/d/graphic/105906.html" rel="external">table 1</a>). The International Pelvic Pain Society has developed a <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ucsfhealth.org%2F-%2Fmedia%2Fproject%2Fucsf%2Fucsf-health%2Fpdf%2Fipps_english.pdf&amp;token=ANI0DG%2FjaoX1vK8YeRNNQUnDAnfLyZbLBKgb5%2FBAjL4dzQQgDJx%2Bka3u%2BWUHeOnkHL%2BODLwWWKEC%2Bd8y3WXFBpZfJ4hRIZqBy94hi3Jurho%3D&amp;TOPIC_ID=5413" target="_blank">history and physical examination form</a> for evaluation of women with chronic pelvic pain of any etiology. During the review of systems, we specifically ask about prior skin disorders (any location), allergies, and diet/nutrition, as these processes can contribute to specified vulvar pain. Excessive urinary oxalate excretion has been purported as a vulvar irritant in patients with vulvodynia but has not been implicated as a cause of localized vulvar pain syndrome [<a href="#rid77">77</a>]. Some patients with localized vulvar pain syndrome find acidic or sugary foods exacerbate vulvar pain. Eliminating certain foods and monitoring pain symptoms can help discern any relationship between diet and localized vulvar pain.</p><p>The gynecologic history can identify other potential causes of the woman's symptoms as well as risk factors for localized vulvar pain syndrome. We ask about prior genital infection, topical treatments, and hormone exposure. Women with localized vulvar pain syndrome often have a history of multiple genital infections. Topical treatments, such as antifungal cream, can cause or worsen dermatitis, which is a specific cause of vulvar pain. Hormone use, particularly with oral contraceptive pills, has been associated with localized vulvar pain syndrome in some studies. In addition, we take a detailed sexual history, assess for female sexual dysfunction (desire, arousal, orgasm, pain), and screen for intimate partner violence. We inquire about pelvic floor dysfunction (eg, urinary or fecal incontinence, prolapse), obstetric injury, and prior abdominal/pelvic surgery. Rarely, renal stones can cause pain in the ipsilateral vulva. Both psychological and anatomic trauma can exacerbate or cause vulvodynia as well as cause specified vulvar pain such as vaginismus. The diagnosis of localized vulvar pain syndrome is made if identifiable specific causes of pelvic and vulvar pain have been treated (eg, antifungals for candida and pelvic floor physiotherapy for vaginismus), related psychological issues have been addressed, and the vestibular pain persists. (See  <a class="medical medical_review" href="/z/d/html/5424.html" rel="external">"Overview of sexual dysfunction in females: Epidemiology, risk factors, and evaluation"</a> and  <a class="medical medical_review" href="/z/d/html/15294.html" rel="external">"Intimate partner violence: Diagnosis and screening"</a> and  <a class="medical medical_review" href="/z/d/html/3253.html" rel="external">"The gynecologic history and pelvic examination", section on 'Urinary incontinence and pelvic organ prolapse'</a>.)</p><p>For the portion of the history focused on the vulvar vestibular symptoms, we specifically inquire about the following:</p><p class="headingAnchor" id="H168455032"><span class="h3">Pain characteristics</span></p><p class="bulletIndent1"><span class="glyph">●</span>Descriptors of pain – Women with localized vulvar pain syndrome can consistently describe, localize, and rate the pain. Nearly 90 percent of women with localized vulvar pain syndrome describe their symptoms as a burning sensation localized to the vulvar vestibule [<a href="#rid5">5</a>]. Other descriptors include sharp, cutting, hot, knife-like, "like razor blades," and throbbing. The pain can be primary (onset with first introital touch, such as sexual activity or tampon use) or secondary (occurring after a period of normal function) [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1">Location – An anatomic diagram that allows the woman to identify the sites of pain is helpful. Localized vulvar pain syndrome is limited to the vestibule or clitoris. Women who cannot locate the sites of pain likely have vulvar pain from another disorder or generalized vulvar pain. </p><p></p><p class="bulletIndent1">Intensity – Additionally, we ask our patients to use a numerical 10-point pain scale to rate their symptoms over time. This helps us understand the duration and severity of pain as well as the impact of pain on the woman's daily activities. (See  <a class="medical medical_review" href="/z/d/html/116196.html" rel="external">"Evaluation of chronic non-cancer pain in adults", section on 'Pain severity and impact'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Timeline of pain – A timeline of pain onset and duration, antecedent events (eg, genital infection, tampon use, intercourse), and treatment is established. Symptoms can be sudden onset or delayed and continuous or intermittent. Symptoms must be present for at least three months to be considered localized vulvar pain syndrome. Women who have symptoms for less than three months are evaluated for vulvar pain from a specific cause  (<a class="graphic graphic_table graphicRef105906" href="/z/d/graphic/105906.html" rel="external">table 1</a>).</p><p></p><p class="headingAnchor" id="H4254826945"><span class="h3">Associated symptoms</span></p><p class="bulletIndent1"><span class="glyph">●</span>Dyspareunia – We ask if the woman has introital dyspareunia. Introital dyspareunia is one of the defining symptoms of vestibulodynia [<a href="#rid52">52</a>]. Women who have general dyspareunia or pain with deep penetration are evaluated for other causes for their symptoms, such as vaginismus or endometriosis. (See  <a class="medical medical_review" href="/z/d/html/5409.html" rel="external">"Female sexual pain: Differential diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tampon use – Women with localized vulvar pain syndrome typically cannot use tampons because of the severe pain with insertion. In a questionnaire study of 30 women with vulvar vestibular pain, nearly half had pain with tampon insertion [<a href="#rid42">42</a>]. If a woman is able to regularly use tampons, she is less likely to have localized vulvar pain syndrome and we evaluate for other causes of her symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Myofascial pain – Myofascial pain syndromes appear to be a risk factor for localized vulvar pain syndrome, and women who have localized vulvar pain syndrome can develop secondary myofascial pain because of progressive tension within the pelvic floor muscles. To screen for myofascial pain, we ask women if they have deep burning pain, pelvic heaviness, or referred pain to other sites. (See <a class="local">'Myofascial'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Menses – In general, menses does not worsen localized vulvar pain syndrome. Women whose symptoms are worse with menses are evaluated for hormonally dependent causes of pelvic pain, such as endometriosis or pelvic congestion syndrome. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/5420.html" rel="external">"Vulvovaginal varicosities and pelvic congestion syndrome"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/z/d/html/134970.html" rel="external">"Endometriosis: Clinical features, evaluation, and diagnosis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Symptoms with semen exposure – Women with localized vulvar pain and seminal plasma allergy can have similar presentations. The difference is women with localized vulvar pain syndrome have symptoms even with condom use but women with seminal plasma allergy do not. (See  <a class="medical medical_review" href="/z/d/html/13529.html" rel="external">"Allergic reactions to seminal plasma"</a>.)</p><p></p><p class="headingAnchor" id="H3557487957"><span class="h3">Psychosocial impact</span></p><p class="bulletIndent1"><span class="glyph">●</span>Psychosocial impact – Women with localized vulvar pain syndrome commonly have compromised sexual function, reduced psychological well-being, and resultant impaired interpersonal relationships. Additionally, routine activities can be affected. We ask women if they avoid or no longer perform certain activities because of their symptoms and how their symptoms impact their relationships. The International Pelvic Pain Society has the most comprehensive <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ucsfhealth.org%2F-%2Fmedia%2Fproject%2Fucsf%2Fucsf-health%2Fpdf%2Fipps_english.pdf&amp;token=ANI0DG%2FjaoX1vK8YeRNNQUnDAnfLyZbLBKgb5%2FBAjL4dzQQgDJx%2Bka3u%2BWUHeOnkHL%2BODLwWWKEC%2Bd8y3WXFBpZfJ4hRIZqBy94hi3Jurho%3D&amp;TOPIC_ID=5413" target="_blank">questionnaire</a> that includes the McGill pain inventory, a picture of the vulva and vestibule for patients to mark painful areas.</p><p></p><p class="headingAnchor" id="H1935170217"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>The cardinal sign of localized vulvar pain syndrome is significant tenderness upon point-pressure testing of the vulvar vestibule. The physical examination also includes visual inspection of the genitalia, palpation of the introitus and vagina, and speculum examination of the vagina and cervix. Even in women with abnormal point-pressure testing of the vestibule, we complete the physical examination in order to exclude other possible causes of the woman's symptoms.</p><p class="headingAnchor" id="H1743514577"><span class="h3">Inspection</span><span class="headingEndMark"> — </span>A main goal of visual inspection is to identify other possible causes for the woman's symptoms, particularly infection, allergy, neoplasm, or dermatosis. We begin by looking at the mons, groin creases, labia majora and minora, clitoris (glans, hood, prepuce, frenulum), urethra, Skene's and greater (Bartholin's) and lesser vestibular glands, perineum, and anus. We are looking for ulcers, plaques, fissures, excoriations, and erythema (diffuse or focal) that could be associated with a specific cause of vulvar pain. We pay particular attention to the vestibular region from four to eight o'clock along the posterior fourchette, which is a common site of redness in women with localized vulvar pain syndrome, although absence of erythema does not exclude the diagnosis, as many patients with vulvodynia have a normal-appearing vestibule. If necessary, we perform tissue biopsy to exclude vulvar dermatoses (eg, lichen sclerosus, psoriasis, lichen planus, atopic dermatitis [eczema], and lichen simplex chronicus) or neoplasm (eg, Paget disease, carcinoma in situ, and squamous cell carcinoma). Lesions suspicious for herpes infection are tested for herpes simplex virus. Episiotomy or surgical scars are inspected for areas of granulation. While use of a colposcope can aid visualization, we avoid using <a class="drug drug_general" data-topicid="9277" href="/z/d/drug information/9277.html" rel="external">acetic acid</a> because it is typically very painful.</p><p class="headingAnchor" id="H3382500249"><span class="h3">Palpation</span><span class="headingEndMark"> — </span>The cardinal sign of localized vulvar pain syndrome is significant tenderness upon point-pressure testing of the vulvar vestibule. The vulvar vestibule is located between the hymenal ring and Hart's line on the medial border of the labia minora  (<a class="graphic graphic_picture graphicRef105677" href="/z/d/graphic/105677.html" rel="external">picture 1</a>). This area represents the transition between the darker keratinized skin of the labia minora and the lighter epithelium containing openings to the urethra, greater (Bartholin) and lesser vestibular glands, as well as Skene's glands.</p><p>We perform point-pressure testing with a cotton-tipped applicator in a circumferential or "paint brush" pattern around the vestibule (eg, similar to a clock face) to map the location and severity of vestibular pain  (<a class="graphic graphic_figure graphicRef105910" href="/z/d/graphic/105910.html" rel="external">figure 2</a>). Women with localized, provoked vulvodynia will have pain out of proportion to the pressure from the touch of the cotton swab, particularly in the areas between four and eight o'clock. We record the woman's pain level (mild, moderate, or severe) at each touch point around the vestibule.</p><p>Next, in women who are able to tolerate vaginal palpation, we check for tenderness of the vagina, bladder, and pelvic floor muscles and for trigger points. During palpation, we ask the patient to quantify any pain sensation as mild, moderate, or severe. We begin the examination by placing a single digit into the woman's vagina. Next, we ask the patient to abduct her thigh against the opposite hand so that we can palpate the obturator internus muscle. Then we palpate the levator ani bilaterally, the subtrigonal region, and along the posterior fourchette. Tenderness of the pelvic floor muscles or bladder trigone can represent vaginismus, myofascial pain, or interstitial cystitis. Lastly, a bimanual examination is performed with either one or two digits within the vagina to assess the contour of the uterus, adnexa, and uterosacral ligaments and exclude causes of pelvic pain such as uterine fibroids, ovarian cysts, and endometriotic nodules. A cross-sectional analysis of 202 women in the United States National Vulvodynia Registry reported higher pelvic floor muscle pain scores may represent different subgroups of provoked vestibulodynia compared with mucosal pain scores elicited from a cotton-swab test, including low arousal and sexual function and satisfaction scores [<a href="#rid78">78</a>]. </p><p class="headingAnchor" id="H2757320400"><span class="h3">Speculum examination</span><span class="headingEndMark"> — </span>A speculum examination is performed with the smallest speculum that allows adequate visualization of the vaginal walls and cervix. We assess for vaginal pallor and loss of rugae suggestive of vaginal atrophy or genitourinary syndrome of menopause. If abnormal vaginal discharge is present, we collect specimens for microscopy and diagnostic testing. (See  <a class="medical medical_review" href="/z/d/html/5464.html" rel="external">"Genitourinary syndrome of menopause (vulvovaginal atrophy): Clinical manifestations and diagnosis"</a> and <a class="local">'Laboratory'</a> below.)</p><p class="headingAnchor" id="H2805342248"><span class="h2">Laboratory</span><span class="headingEndMark"> — </span>Localized vulvar pain syndrome does not cause laboratory abnormalities. Laboratory evaluation is done to exclude other causes for the patient's symptoms. For example, if abnormal vaginal or cervical discharge is present, we perform microscopy to assess for common causes of vaginal infection (bacterial vaginosis, candida vulvovaginitis) and test for gonorrhea, chlamydia, and trichomoniasis. Women with pelvic pain commonly have a urinalysis or urine culture performed to exclude infection. Vulvar lesions are biopsied and examined to exclude inflammatory or neoplastic processes (eg, lichen sclerosus, squamous cell carcinoma). However, biopsy is not required to diagnose localized vulvar pain syndrome because the syndrome does not have pathognomonic histological features. (See  <a class="medical medical_review" href="/z/d/html/5451.html" rel="external">"Bacterial vaginosis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5452.html" rel="external">"Candida vulvovaginitis: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/15893.html" rel="external">"Clinical manifestations and diagnosis of <i>Neisseria gonorrhoeae </i>infection in adults and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/83019.html" rel="external">"Clinical manifestations and diagnosis of <i>Chlamydia trachomatis </i>infections"</a> and  <a class="medical medical_review" href="/z/d/html/5453.html" rel="external">"Trichomoniasis: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H4059107962"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>Localized vulvar pain syndrome does not cause imaging abnormalities. Imaging techniques can be useful to identify other causes of pain. As an example, most women with pelvic pain undergo transvaginal ultrasound to assess for uterine fibroids or ovarian cysts. Patients with symptoms or risk factors for kidney stones may benefit from imaging to exclude this diagnosis.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/5467.html" rel="external">"Chronic pelvic pain in adult females: Evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7366.html" rel="external">"Kidney stones in adults: Diagnosis and acute management of suspected nephrolithiasis", section on 'Diagnostic imaging'</a>.)</p><p></p><p class="headingAnchor" id="H3700027140"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Localized vulvar pain syndrome is a clinical diagnosis based upon physical examination confirming significant pain during point-pressure testing of the vulvar vestibule with a cotton-tipped applicator  (<a class="graphic graphic_figure graphicRef105910" href="/z/d/graphic/105910.html" rel="external">figure 2</a>) in women who have had vestibular pain for at least three months and have no other identifiable cause. (See <a class="local">'Diagnostic criteria'</a> above.)</p><p>Asymptomatic women can also have a positive response to cotton-swab testing and cannot be considered as having vulvodynia based on this testing alone [<a href="#rid79">79</a>]. Supportive history includes description of a burning pain, inability to have vaginal sexual contact or use a tampon, and interference with relationships and routine activities.</p><p class="headingAnchor" id="H3628107754"><span class="h1">COEXISTING PAIN SYNDROMES</span><span class="headingEndMark"> — </span>Other pain syndromes appear to be more common in some women with localized vulvar pain syndrome. In a study of over 1900 women, vulvodynia was associated with fibromyalgia, interstitial cystitis, and irritable bowel syndrome [<a href="#rid80">80</a>]. Similarly, in a study of 122 women with vulvodynia, 80 percent screened positive for interstitial cystitis [<a href="#rid81">81</a>]. It is not known if localized vulvar pain syndrome represents referred pain from these other sites, different manifestations of the same underlying etiology, or part of a more broad multidimensional etiology. As an example, in a questionnaire study of 137 women with localized vulvar pain syndrome, nearly 80 percent also reported orofacial pain (OFP) symptoms [<a href="#rid82">82</a>]. Additionally, when compared with women who had no OFP symptoms, women with symptoms reported higher levels of anxiety, somatization, and psychologic distress.</p><p>Based on the above studies, we screen women suspected of having localized vulvar pain syndrome for additional pain syndromes, particularly interstitial cystitis. (See  <a class="medical medical_review" href="/z/d/html/8085.html" rel="external">"Interstitial cystitis/bladder pain syndrome: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5624.html" rel="external">"Clinical manifestations and diagnosis of fibromyalgia in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2630.html" rel="external">"Clinical manifestations and diagnosis of irritable bowel syndrome in adults"</a>.)</p><p class="headingAnchor" id="H2013336931"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Treatment of vulvodynia, including localized vulvar pain syndrome, is reviewed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/110586.html" rel="external">"Vulvar pain of unknown cause (vulvodynia): Treatment"</a>.)</p><p class="headingAnchor" id="H626742092"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/126553.html" rel="external">"Society guideline links: Female pelvic pain"</a>.)</p><p class="headingAnchor" id="H759718987"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Terminology</strong> – Localized vulvar pain syndrome is a vulvodynia involving the vulvar vestibule and possibly the clitoris. In contrast to vulvar pain disorders due to a specific cause, localized vulvar pain syndrome has no identifiable cause. (See <a class="local">'Terminology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – The etiology of localized vulvar pain syndrome is not fully known and is likely multifactorial. The leading hypothesis is that an inciting event, such as infection or trauma, initiates a local inflammatory response. In susceptible women, the inflammatory response causes the proliferation of nerve fibers in the vestibular tissue and lowered pain thresholds, which can then lead to central sensitization of pain. (See <a class="local">'Pathogenesis and likely contributors'</a> above.)</p><p></p><p class="bulletIndent1">Specific contributors to localized vulvar pain syndrome include infectious, inflammatory, neurologic, genetic, allergic, hormonal, myofascial, and psychological processes. While psychological dysfunction does not appear to cause vulvar or vestibular pain, the chronic pain of vulvodynia can lead to secondary psychological and mental health disorders. (See <a class="local">'Pathogenesis and likely contributors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic criteria</strong> – Diagnostic criteria for localized vulvar pain syndrome include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pain localized to the vulvar vestibule and possibly the clitoris</p><p class="bulletIndent2"><span class="glyph">•</span>Absence of identifiable cause</p><p class="bulletIndent2"><span class="glyph">•</span>Duration of at least three months</p><p class="bulletIndent2"><span class="glyph">•</span>Pain elicited with pressure-point testing </p><p></p><p class="bulletIndent1">Symptom onset can occur with initial vestibular contact (primary) or develop after a period of normal function (secondary). Symptom timing after vestibular contact can be immediate or delayed and symptom pattern can be intermittent, persistent (nonrelapsing), or constant (continuous). Additionally, some women have both localized vulvar pain syndrome and an identifiable vulvar pain disorder with a known, reversible cause. (See <a class="local">'Diagnostic criteria'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> – Women with localized vulvar pain syndrome present with significant pain upon contact with the vulvar vestibule  (<a class="graphic graphic_picture graphicRef105677" href="/z/d/graphic/105677.html" rel="external">picture 1</a>). Common complaints include pain with vaginal intercourse, tampon insertion, tight clothing, prolonged sitting, biking, or other sports. (See <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong> – The diagnostic evaluation consists of a detailed history and physical examination that includes focal pressure-point testing of the vulvar vestibule. One purpose of the evaluation is to identify potential specific causes of the woman's pain, as localized vulvar pain syndrome is a diagnosis of exclusion. However, the diagnostic process can be confusing as vulvar pain from a specific cause can coexist with localized vulvar pain syndrome. (See <a class="local">'Diagnostic evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>History</strong> – The history includes a comprehensive review of systems, detailed gynecologic history, and vulvar pain history to characterize the patient’s pain and identify potential specific causes of vulvar pain  (<a class="graphic graphic_table graphicRef105906" href="/z/d/graphic/105906.html" rel="external">table 1</a>). Women with localized vulvar pain syndrome can consistently localize and rate their pain, which is commonly described as a burning sensation. (See <a class="local">'History'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Physical examination and findings</strong> – The cardinal sign of localized vulvar pain syndrome is significant tenderness upon point-pressure testing of the vulvar vestibule. The pain is mapped by location and severity with a cotton-tipped applicator  (<a class="graphic graphic_figure graphicRef105910" href="/z/d/graphic/105910.html" rel="external">figure 2</a>). Visual inspection, vaginal and bimanual examinations, and speculum examination are also performed to identify other possible causes of pain. (See <a class="local">'Physical examination'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Laboratory and imaging</strong> –Localized vulvar pain syndrome does not cause laboratory or imaging abnormalities. However, laboratory tests such as microscopy; testing for gonorrhea, chlamydia, and trichomonas; and urinalysis or urine culture can be useful to exclude infectious causes. Similarly, pelvic ultrasound is commonly performed as part of the evaluation for pelvic pain. (See <a class="local">'Laboratory'</a> above and <a class="local">'Imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>–<strong> </strong>Localized vulvar pain syndrome is a clinical diagnosis based upon physical examination confirming significant pain during point-pressure testing of the vulvar vestibule  (<a class="graphic graphic_figure graphicRef105910" href="/z/d/graphic/105910.html" rel="external">figure 2</a>). Supportive history includes description of a burning pain, inability to use have vaginal sexual contact or use a tampon, and interference with relationships and routine activities. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Coexisting pain syndromes</strong> – Other pain syndromes appear to be more common in some women with localized vulvar pain syndrome. It is not known if localized vulvar pain syndrome represents referred pain from these sites or if these syndromes are different manifestations of the same underlying etiology. We screen women suspected of having localized vulvar pain syndrome for additional pain syndromes, particularly interstitial cystitis. (See <a class="local">'Coexisting pain syndromes'</a> above.)</p><p></p><p class="headingAnchor" id="H2966994526"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Elizabeth Gunther Stewart, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Bornstein J, Goldstein AT, Stockdale CK, et al. 2015 ISSVD, ISSWSH and IPPS Consensus Terminology and Classification of Persistent Vulvar Pain and Vulvodynia. Obstet Gynecol 2016; 127:745.</a></li><li><a class="nounderline abstract_t">Bornstein J, Preti M, Simon JA, et al. Descriptors of Vulvodynia: A Multisocietal Definition Consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society). J Low Genit Tract Dis 2019; 23:161.</a></li><li><a class="nounderline abstract_t">Bonham A. Vulvar vestibulodynia: strategies to meet the challenge. Obstet Gynecol Surv 2015; 70:274.</a></li><li><a class="nounderline abstract_t">Friedrich EG Jr. Vulvar vestibulitis syndrome. J Reprod Med 1987; 32:110.</a></li><li><a class="nounderline abstract_t">Bergeron S, Binik YM, Khalifé S, et al. Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria. Obstet Gynecol 2001; 98:45.</a></li><li><a class="nounderline abstract_t">Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc (1972) 2003; 58:82.</a></li><li><a class="nounderline abstract_t">Reed BD, Crawford S, Couper M, et al. Pain at the vulvar vestibule: a web-based survey. J Low Genit Tract Dis 2004; 8:48.</a></li><li><a class="nounderline abstract_t">Reed BD, Haefner HK, Harlow SD, et al. Reliability and validity of self-reported symptoms for predicting vulvodynia. Obstet Gynecol 2006; 108:906.</a></li><li><a class="nounderline abstract_t">Metts JF. Vulvodynia and vulvar vestibulitis: challenges in diagnosis and management. Am Fam Physician 1999; 59:1547.</a></li><li><a class="nounderline abstract_t">Akopians AL, Rapkin AJ. Vulvodynia: The Role of Inflammation in the Etiology of Localized Provoked Pain of the Vulvar Vestibule (Vestibulodynia). Semin Reprod Med 2015; 33:239.</a></li><li><a class="nounderline abstract_t">Barnabei VM. Vulvodynia. Clin Obstet Gynecol 2020; 63:752.</a></li><li><a class="nounderline abstract_t">Chisari C, Monajemi MB, Scott W, et al. Psychosocial factors associated with pain and sexual function in women with Vulvodynia: A systematic review. Eur J Pain 2021; 25:39.</a></li><li><a class="nounderline abstract_t">Miranda Varella Pereira G, Soriano Marcolino M, Silveira Nogueira Reis Z, Vale de Castro Monteiro M. A systematic review of drug treatment of vulvodynia: evidence of a strong placebo effect. BJOG 2018; 125:1216.</a></li><li><a class="nounderline abstract_t">Reed BD, Harlow SD, Sen A, et al. Prevalence and demographic characteristics of vulvodynia in a population-based sample. Am J Obstet Gynecol 2012; 206:170.e1.</a></li><li><a class="nounderline abstract_t">Reed BD, Harlow SD, Plegue MA, Sen A. Remission, Relapse, and Persistence of Vulvodynia: A Longitudinal Population-Based Study. J Womens Health (Larchmt) 2016; 25:276.</a></li><li><a class="nounderline abstract_t">Harris V, Fischer G, Bradford JA. The aetiology of chronic vulval pain and entry dyspareunia: a retrospective review of 525 cases. Aust N Z J Obstet Gynaecol 2017; 57:446.</a></li><li><a class="nounderline abstract_t">De Andres J, Sanchis-Lopez N, Asensio-Samper JM, et al. Vulvodynia--An Evidence-Based Literature Review and Proposed Treatment Algorithm. Pain Pract 2016; 16:204.</a></li><li><a class="nounderline abstract_t">Clare CA, Yeh J. Vulvodynia in adolescence: childhood vulvar pain syndromes. J Pediatr Adolesc Gynecol 2011; 24:110.</a></li><li><a class="nounderline abstract_t">Weström LV, Willén R. Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet Gynecol 1998; 91:572.</a></li><li><a class="nounderline abstract_t">Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 1998; 46:256.</a></li><li><a class="nounderline abstract_t">Wesselmann U, Bonham A, Foster D. Vulvodynia: Current state of the biological science. Pain 2014; 155:1696.</a></li><li><a class="nounderline abstract_t">Chalmers KJ, Madden VJ, Hutchinson MR, Moseley GL. Local and Systemic Inflammation in Localized, Provoked Vestibulodynia: A Systematic Review. Obstet Gynecol 2016; 128:337.</a></li><li><a class="nounderline abstract_t">Ventolini G, Gygax SE, Adelson ME, Cool DR. Vulvodynia and fungal association: a preliminary report. Med Hypotheses 2013; 81:228.</a></li><li><a class="nounderline abstract_t">Foster DC, Falsetta ML, Woeller CF, et al. Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women. Pain 2015; 156:386.</a></li><li><a class="nounderline abstract_t">Foster DC, Hasday JD. Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis. Obstet Gynecol 1997; 89:291.</a></li><li><a class="nounderline abstract_t">Falsetta ML, Foster DC, Woeller CF, et al. Identification of novel mechanisms involved in generating localized vulvodynia pain. Am J Obstet Gynecol 2015; 213:38.e1.</a></li><li><a class="nounderline abstract_t">Lundqvist EN, Hofer PA, Olofsson JI, Sjöberg I. Is vulvar vestibulitis an inflammatory condition? A comparison of histological findings in affected and healthy women. Acta Derm Venereol 1997; 77:319.</a></li><li><a class="nounderline abstract_t">Slone S, Reynolds L, Gall S, et al. Localization of chromogranin, synaptophysin, serotonin, and CXCR2 in neuroendocrine cells of the minor vestibular glands: an immunohistochemical study. Int J Gynecol Pathol 1999; 18:360.</a></li><li><a class="nounderline abstract_t">Bohm-Starke N, Falconer C, Rylander E, Hilliges M. The expression of cyclooxygenase 2 and inducible nitric oxide synthase indicates no active inflammation in vulvar vestibulitis. Acta Obstet Gynecol Scand 2001; 80:638.</a></li><li><a class="nounderline abstract_t">Tympanidis P, Terenghi G, Dowd P. Increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol 2003; 148:1021.</a></li><li><a class="nounderline abstract_t">Halperin R, Zehavi S, Vaknin Z, et al. The major histopathologic characteristics in the vulvar vestibulitis syndrome. Gynecol Obstet Invest 2005; 59:75.</a></li><li><a class="nounderline abstract_t">Tympanidis P, Casula MA, Yiangou Y, et al. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain 2004; 8:129.</a></li><li><a class="nounderline abstract_t">Fenton BW. Limbic associated pelvic pain: a hypothesis to explain the diagnostic relationships and features of patients with chronic pelvic pain. Med Hypotheses 2007; 69:282.</a></li><li><a class="nounderline abstract_t">Hampson JP, Reed BD, Clauw DJ, et al. Augmented central pain processing in vulvodynia. J Pain 2013; 14:579.</a></li><li><a class="nounderline abstract_t">Pukall CF, Binik YM, Khalifé S, et al. Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome. Pain 2002; 96:163.</a></li><li><a class="nounderline abstract_t">Zolnoun D, Bair E, Essick G, et al. Reliability and reproducibility of novel methodology for assessment of pressure pain sensitivity in pelvis. J Pain 2012; 13:910.</a></li><li><a class="nounderline abstract_t">Zhang Z, Zolnoun DA, Francisco EM, et al. Altered central sensitization in subgroups of women with vulvodynia. Clin J Pain 2011; 27:755.</a></li><li><a class="nounderline abstract_t">Foster DC, Dworkin RH, Wood RW. Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted women. Pain 2005; 117:128.</a></li><li><a class="nounderline abstract_t">Chen A, De E, Argoff C. Small Fiber Polyneuropathy Is Prevalent in Patients Experiencing Complex Chronic Pelvic Pain. Pain Med 2019; 20:521.</a></li><li><a class="nounderline abstract_t">Nguyen RH, Swanson D, Harlow BL. Urogenital infections in relation to the occurrence of vulvodynia. J Reprod Med 2009; 54:385.</a></li><li><a class="nounderline abstract_t">Edgardh K, Abdelnoor M. Vulvar vestibulitis and risk factors: a population-based case-control study in Oslo. Acta Derm Venereol 2007; 87:350.</a></li><li><a class="nounderline abstract_t">Donders G, Bellen G. Characteristics of the pain observed in the focal vulvodynia syndrome (VVS). Med Hypotheses 2012; 78:11.</a></li><li><a class="nounderline abstract_t">Arnold LD, Bachmann GA, Rosen R, et al. Vulvodynia: characteristics and associations with comorbidities and quality of life. Obstet Gynecol 2006; 107:617.</a></li><li><a class="nounderline abstract_t">Ponte M, Klemperer E, Sahay A, Chren MM. Effects of vulvodynia on quality of life. J Am Acad Dermatol 2009; 60:70.</a></li><li><a class="nounderline abstract_t">Jeremias J, Ledger WJ, Witkin SS. Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am J Obstet Gynecol 2000; 182:283.</a></li><li><a class="nounderline abstract_t">Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS. Interleukin-1beta gene polymorphism in women with vulvar vestibulitis syndrome. Eur J Obstet Gynecol Reprod Biol 2003; 107:74.</a></li><li><a class="nounderline abstract_t">Babula O, Danielsson I, Sjoberg I, et al. Altered distribution of mannose-binding lectin alleles at exon I codon 54 in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2004; 191:762.</a></li><li><a class="nounderline abstract_t">Babula O, Linhares IM, Bongiovanni AM, et al. Association between primary vulvar vestibulitis syndrome, defective induction of tumor necrosis factor-alpha, and carriage of the mannose-binding lectin codon 54 gene polymorphism. Am J Obstet Gynecol 2008; 198:101.e1.</a></li><li><a class="nounderline abstract_t">Gerber S, Witkin SS, Stucki D. Immunological and genetic characterization of women with vulvodynia. J Med Life 2008; 1:432.</a></li><li><a class="nounderline abstract_t">Gerber S, Bongiovanni AM, Ledger WJ, Witkin SS. Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2002; 186:696.</a></li><li><a class="nounderline abstract_t">Pociot F, Mølvig J, Wogensen L, et al. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22:396.</a></li><li><a class="nounderline abstract_t">Goldstein AT, Belkin ZR, Krapf JM, et al. Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med 2014; 11:2764.</a></li><li><a class="nounderline abstract_t">Hersh JE. Vulvodynia in adolescents: presentation, diagnosis and treatment options. Curr Opin Obstet Gynecol 2018; 30:293.</a></li><li><a class="nounderline abstract_t">Ledger WJ, Kessler A, Leonard GH, Witkin SS. Vulvar vestibulitis-a complex clinical entity. Infect Dis Obstet Gynecol 1996; 4:269.</a></li><li><a class="nounderline abstract_t">Chadha S, Gianotten WL, Drogendijk AC, et al. Histopathologic features of vulvar vestibulitis. Int J Gynecol Pathol 1998; 17:7.</a></li><li><a class="nounderline abstract_t">Ramirez De Knott HM, McCormick TS, Do SO, et al. Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia. Contact Dermatitis 2005; 53:214.</a></li><li><a class="nounderline abstract_t">Eva LJ, MacLean AB, Reid WM, et al. Estrogen receptor expression in vulvar vestibulitis syndrome. Am J Obstet Gynecol 2003; 189:458.</a></li><li><a class="nounderline abstract_t">Johannesson U, Sahlin L, Masironi B, et al. Steroid receptor expression and morphology in provoked vestibulodynia. Am J Obstet Gynecol 2008; 198:311.e1.</a></li><li><a class="nounderline abstract_t">Harlow BL, Vitonis AF, Stewart EG. Influence of oral contraceptive use on the risk of adult-onset vulvodynia. J Reprod Med 2008; 53:102.</a></li><li><a class="nounderline abstract_t">Reed BD, Harlow SD, Legocki LJ, et al. Oral contraceptive use and risk of vulvodynia: a population-based longitudinal study. BJOG 2013; 120:1678.</a></li><li><a class="nounderline abstract_t">Bohm-Starke N, Hilliges M, Blomgren B, et al. Increased blood flow and erythema in the posterior vestibular mucosa in vulvar vestibulitis(1). Obstet Gynecol 2001; 98:1067.</a></li><li><a class="nounderline abstract_t">Bouchard C, Brisson J, Fortier M, et al. Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. Am J Epidemiol 2002; 156:254.</a></li><li><a class="nounderline abstract_t">Bazin S, Bouchard C, Brisson J, et al. Vulvar vestibulitis syndrome: an exploratory case-control study. Obstet Gynecol 1994; 83:47.</a></li><li><a class="nounderline abstract_t">Greenstein A, Ben-Aroya Z, Fass O, et al. Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills. J Sex Med 2007; 4:1679.</a></li><li><a class="nounderline abstract_t">Nguyen RH, Mathur C, Wynings EM, et al. Remission of vulvar pain among women with primary vulvodynia. J Low Genit Tract Dis 2015; 19:62.</a></li><li><a class="nounderline abstract_t">Reissing ED, Brown C, Lord MJ, et al. Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome. J Psychosom Obstet Gynaecol 2005; 26:107.</a></li><li><a class="nounderline abstract_t">Butrick CW. Pelvic floor hypertonic disorders: identification and management. Obstet Gynecol Clin North Am 2009; 36:707.</a></li><li><a class="nounderline abstract_t">Gentilcore-Saulnier E, McLean L, Goldfinger C, et al. Pelvic floor muscle assessment outcomes in women with and without provoked vestibulodynia and the impact of a physical therapy program. J Sex Med 2010; 7:1003.</a></li><li><a class="nounderline abstract_t">Granot M, Lavee Y. Psychological factors associated with perception of experimental pain in vulvar vestibulitis syndrome. J Sex Marital Ther 2005; 31:285.</a></li><li><a class="nounderline abstract_t">Alappattu MJ, Bishop MD. Psychological factors in chronic pelvic pain in women: relevance and application of the fear-avoidance model of pain. Phys Ther 2011; 91:1542.</a></li><li><a class="nounderline abstract_t">Shallcross R, Dickson JM, Nunns D, et al. Women's Subjective Experiences of Living with Vulvodynia: A Systematic Review and Meta-Ethnography. Arch Sex Behav 2018; 47:577.</a></li><li><a class="nounderline abstract_t">Netzer I, Gal L, Rubinstein R. Medical and psychological comorbidity in vulvodynia in young adults: a case-controlled study. J Sex Med 2017; 14:e107.</a></li><li><a class="nounderline abstract_t">Chandan JS, Keerthy D, Gokhale KM, et al. The association between exposure to domestic abuse in women and the development of syndromes indicating central nervous system sensitization: A retrospective cohort study using UK primary care records. Eur J Pain 2021; 25:1283.</a></li><li><a class="nounderline abstract_t">Mühlrad H, Haraldson P, Harlow BL, et al. Early Life Health in Women with Provoked Vestibulodynia and/or Vaginismus. J Womens Health (Larchmt) 2021; 30:799.</a></li><li><a class="nounderline abstract_t">Reed BD, Cantor LE. Vulvodynia in preadolescent girls. J Low Genit Tract Dis 2008; 12:257.</a></li><li><a class="nounderline abstract_t">McKay M. Vulvodynia. A multifactorial clinical problem. Arch Dermatol 1989; 125:256.</a></li><li><a class="nounderline abstract_t">Haefner HK, Collins ME, Davis GD, et al. The vulvodynia guideline. J Low Genit Tract Dis 2005; 9:40.</a></li><li><a class="nounderline abstract_t">Lo L, Lamvu G, Alappattu M, et al. Predictors of Mucosal and Muscle Pain in Vulvodynia: A Cross-Sectional Analysis From the National Vulvodynia Registry. J Pain 2021; 22:161.</a></li><li><a class="nounderline abstract_t">Vieira-Baptista P, Lima-Silva J, Beires J, Donders G. Women without vulvodynia can have a positive 'Q-tip test': a cross sectional study. J Psychosom Obstet Gynaecol 2017; 38:256.</a></li><li><a class="nounderline abstract_t">Reed BD, Harlow SD, Sen A, et al. Relationship between vulvodynia and chronic comorbid pain conditions. Obstet Gynecol 2012; 120:145.</a></li><li><a class="nounderline abstract_t">Kahn BS, Tatro C, Parsons CL, Willems JJ. Prevalence of interstitial cystitis in vulvodynia patients detected by bladder potassium sensitivity. J Sex Med 2010; 7:996.</a></li><li><a class="nounderline abstract_t">Zolnoun DA, Rohl J, Moore CG, et al. Overlap between orofacial pain and vulvar vestibulitis syndrome. Clin J Pain 2008; 24:187.</a></li></ol></div><div id="topicVersionRevision">Topic 5413 Version 39.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27008217" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : 2015 ISSVD, ISSWSH and IPPS Consensus Terminology and Classification of Persistent Vulvar Pain and Vulvodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30768446" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Descriptors of Vulvodynia: A Multisocietal Definition Consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25900527" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Vulvar vestibulodynia: strategies to meet the challenge.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3560069" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Vulvar vestibulitis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11430955" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12744420" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15874837" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pain at the vulvar vestibule: a web-based survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17012453" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Reliability and validity of self-reported symptoms for predicting vulvodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10193596" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Vulvodynia and vulvar vestibulitis: challenges in diagnosis and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26132928" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Vulvodynia: The Role of Inflammation in the Etiology of Localized Provoked Pain of the Vulvar Vestibule (Vestibulodynia).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33074981" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Vulvodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33001545" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Psychosocial factors associated with pain and sexual function in women with Vulvodynia: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29569822" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : A systematic review of drug treatment of vulvodynia: evidence of a strong placebo effect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21963307" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Prevalence and demographic characteristics of vulvodynia in a population-based sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26752153" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Remission, Relapse, and Persistence of Vulvodynia: A Longitudinal Population-Based Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28294284" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The aetiology of chronic vulval pain and entry dyspareunia: a retrospective review of 525 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25581081" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Vulvodynia--An Evidence-Based Literature Review and Proposed Treatment Algorithm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21601807" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Vulvodynia in adolescence: childhood vulvar pain syndromes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9540943" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9813445" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Increased intraepithelial innervation in women with vulvar vestibulitis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24858303" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Vulvodynia: Current state of the biological science.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27400010" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Local and Systemic Inflammation in Localized, Provoked Vestibulodynia: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23707510" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Vulvodynia and fungal association: a preliminary report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25679469" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9015038" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25683963" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Identification of novel mechanisms involved in generating localized vulvodynia pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9228230" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Is vulvar vestibulitis an inflammatory condition? A comparison of histological findings in affected and healthy women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10542945" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Localization of chromogranin, synaptophysin, serotonin, and CXCR2 in neuroendocrine cells of the minor vestibular glands: an immunohistochemical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11437722" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : The expression of cyclooxygenase 2 and inducible nitric oxide synthase indicates no active inflammation in vulvar vestibulitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12786836" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Increased innervation of the vulval vestibule in patients with vulvodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15542936" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The major histopathologic characteristics in the vulvar vestibulitis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14987622" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Increased vanilloid receptor VR1 innervation in vulvodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17292560" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Limbic associated pelvic pain: a hypothesis to explain the diagnostic relationships and features of patients with chronic pelvic pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23578957" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Augmented central pain processing in vulvodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11932072" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22958875" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Reliability and reproducibility of novel methodology for assessment of pressure pain sensitivity in pelvis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21593667" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Altered central sensitization in subgroups of women with vulvodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16087295" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29447372" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Small Fiber Polyneuropathy Is Prevalent in Patients Experiencing Complex Chronic Pelvic Pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19639929" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Urogenital infections in relation to the occurrence of vulvodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17598040" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Vulvar vestibulitis and risk factors: a population-based case-control study in Oslo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22041052" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Characteristics of the pain observed in the focal vulvodynia syndrome (VVS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16507933" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Vulvodynia: characteristics and associations with comorbidities and quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19022532" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Effects of vulvodynia on quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10694325" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12593899" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Interleukin-1beta gene polymorphism in women with vulvar vestibulitis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15467537" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Altered distribution of mannose-binding lectin alleles at exon I codon 54 in women with vulvar vestibulitis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18166320" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Association between primary vulvar vestibulitis syndrome, defective induction of tumor necrosis factor-alpha, and carriage of the mannose-binding lectin codon 54 gene polymorphism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20108524" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Immunological and genetic characterization of women with vulvodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11967493" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1353022" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25187224" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30153128" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Vulvodynia in adolescents: presentation, diagnosis and treatment options.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18476106" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Vulvar vestibulitis-a complex clinical entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9475185" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Histopathologic features of vulvar vestibulitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16191018" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14520218" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Estrogen receptor expression in vulvar vestibulitis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18177837" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Steroid receptor expression and morphology in provoked vestibulodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18357801" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Influence of oral contraceptive use on the risk of adult-onset vulvodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23937077" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Oral contraceptive use and risk of vulvodynia: a population-based longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11755555" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Increased blood flow and erythema in the posterior vestibular mucosa in vulvar vestibulitis(1).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12142260" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Use of oral contraceptive pills and vulvar vestibulitis: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8272306" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Vulvar vestibulitis syndrome: an exploratory case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17970976" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24859843" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Remission of vulvar pain among women with primary vulvodynia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16050536" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19932423" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Pelvic floor hypertonic disorders: identification and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20059663" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Pelvic floor muscle assessment outcomes in women with and without provoked vestibulodynia and the impact of a physical therapy program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16020147" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Psychological factors associated with perception of experimental pain in vulvar vestibulitis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21835893" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Psychological factors in chronic pelvic pain in women: relevance and application of the fear-avoidance model of pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28905128" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Women's Subjective Experiences of Living with Vulvodynia: A Systematic Review and Meta-Ethnography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Medical and psychological comorbidity in vulvodynia in young adults: a case-controlled study</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33559289" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The association between exposure to domestic abuse in women and the development of syndromes indicating central nervous system sensitization: A retrospective cohort study using UK primary care records.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33395559" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Early Life Health in Women with Provoked Vestibulodynia and/or Vaginismus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18820538" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Vulvodynia in preadolescent girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2643930" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Vulvodynia. A multifactorial clinical problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15870521" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : The vulvodynia guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32679255" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Predictors of Mucosal and Muscle Pain in Vulvodynia: A Cross-Sectional Analysis From the National Vulvodynia Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28511610" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Women without vulvodynia can have a positive 'Q-tip test': a cross sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22914403" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Relationship between vulvodynia and chronic comorbid pain conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19845546" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Prevalence of interstitial cystitis in vulvodynia patients detected by bladder potassium sensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18287822" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Overlap between orofacial pain and vulvar vestibulitis syndrome.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
